Clinical Trials
31 trialsStudy of Outcomes of Radiofrequency Ablation of Lung Tumors
University of Pittsburgh
Clinical Effectiveness and Safety of SHR-A1811 in Chinese Patients With HER2-Altered NSCLC
Nanjing Tianyinshan Hospital
Prediction of Outcome to Neoadjuvant Therapy in Non-small Cell Lung Cancer（NSCLC）
Tongji Hospital
Oncomabs
Oslo University Hospital
EoYLC
Addario Lung Cancer Medical Institute
Multimodal Model Predicts Treatment Efficacy and CIP Risk in Advanced NSCLC With Immunotherapy and Chemotherapy
Shanghai Zhongshan Hospital
Analysis of Deoxyribonucleic Acid and Ribonucleic Acid Next-Generation Sequencing in Non-Small Cell Lung Cancer Patients Without Pathological Complete Response Following Neoadjuvant Immunotherapy
Tianjin Medical University Cancer Institute and Hospital
ELDAPT
Maastricht Radiation Oncology
KEAPnes
Regina Elena Cancer Institute
Korean Registry of Non-Small Cell Lung Cancer Patients with EGFR Mutation
Yuhan Corporation
A Study With Central Nervous System Metastatic EGFR Mutation Positive Non-small Cell Lung Cancer
Hunan Province Tumor Hospital
Testing Tumor Tissue and Blood to Help Select Personalized Treatments for Patients With Suspected Lung Cancers
Lung Cancer Mutation Consortium
DECIDE
The Netherlands Cancer Institute
A Real-World Study of Atezolizumab in Combination With Platinum-Based Doublet Chemotherapy as Neoadjuvant Therapy for Resectable Stage II-IIIB NSCLC
Hunan Province Tumor Hospital
MRDinS3LC
Peking University Cancer Hospital & Institute
18F-FDG PET/CT to Evaluate pD-1 Monoclonal Antibody With First-line Chemotherapy in Advanced NSCLC
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
A Real-world Study: Efficacy and Safety of Anlotinib for Advanced Non-small Cell Lung Cancer(NSCLC)
Tongji Hospital
NSCLC
Henan Cancer Hospital
Whether Sputum Can Serve as an Alternative Source for Liquid Biopsy in Patients With Lung Cancer
Guangzhou Institute of Respiratory Disease
IMMUNOBZH
University Hospital, Brest
TUMOVASC
University Hospital, Strasbourg, France
NSCLC
Fudan University
BELLA
Guangdong Association of Clinical Trials
HeXeRT
Sheffield Teaching Hospitals NHS Foundation Trust
Photon Versus Particle Therapy for Recurrent Lung Cancer; a Planning Study Based on a Reference Dataset of Patients.
Maastricht Radiation Oncology
The Correlation of PD-L1 Expression in Non-small Lung Cancer Tissue and Peripheral Blood T Cell and Serum.
Xinqiao Hospital of Chongqing
Comprehensive Analysis of Gene Mutation Profile in Chinese NSCLC Patients by Next-generation Sequencing
Tianjin Medical University Cancer Institute and Hospital
Drug Sensitivity Correlation Between Patient-Derived Organoid Model and Clinical Response in NSCLC Patients
K2 Oncology, Inc.
Circulating Fibrocytes in Non-small Cell Lung Cancer.
Chang Gung Memorial Hospital
A Retrospective Molecular Epidemiology Study in Singapore Patients With Advanced Non Small Cell Lung Cancer (NSCLC) of Adenocarcinoma Histology to Assess Epidermal Growth Factor Receptor (EGFR) Mutation Status
National University Hospital, Singapore
FACPT
The First Affiliated Hospital of Guangzhou Medical University